Sweden Cancerome Analysis Network - Breast : Genomic Profiling of Breast Cancer
SCAN-B: The Sweden Cancerome Analysis Network - Breast Initiative
Lund University
20,000 participants
Aug 1, 2010
OBSERVATIONAL
Conditions
Summary
This study evaluates the genomic profiles of breast cancer in a prospective and population-based manner. In the first phase, breast tumors are analyzed by whole transcriptome RNA-sequencing. Gene expression profiles, mutational profiles, and transcript isoform-level data will be analyzed in the context of patient information, clinicopathological variables, and outcome, with the purpose to develop new molecular diagnostic assays for breast cancer. Additional genome-scale RNA, DNA, and protein analyses will be performed in the future.
Eligibility
Inclusion Criteria2
- suspicion or confirmed diagnosis of primary breast cancer
- signed informed consent
Exclusion Criteria1
- lack of signed informed consent
Locations(9)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02306096